Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Marcia Nizzari, Andy Page


Marcia Nizzari has been named vice president of engineering at PatientsLikeMe. She joins the company from Good Start Genetics, where she was the director of bioinformatics and high performance computing/IT. Previously, she was director of informatics for the Program in Medical and Population Genetics at the Broad Institute.

23andMe has appointed Andy Page to president, a newly created senior executive position. He will report to CEO Anne Wojcicki, and will be responsible for the company's product and engineering, marketing, finance, business development, laboratory operations, and legal/regulator affairs. Page has been a member of 23andMe's board of directors since 2012 and will remain on the board.

He previously served as president of Gilt Groupe, an online luxury shopping destination, and as chief operating and financial officer at PlayPhone.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.